Omniflow II biosynthetic vascular prosthesis - Adef-Rio

More documents

Recommendations

Info

Reduced risk of infection First choice for patients susceptible to infection • Smooth flow surface prevents bacterial invasion Femoropopliteal bypass Arteriovenous access • Graft re<strong>vascular</strong>isation facilitates immune response and antibiotic therapy • Clinical data demonstrates superiority to synthetic prostheses Koch G et al. Zentralbl Chir 1996; 121: 761-767 Enzler et al. Clin Transplant 1996; 10: 511-515 BN 9-12(0)-1
Biosynthetic solution overcomes issues Autologous fistula or saphenous vein Other autologous vessel(s) • Deep veins • Arm veins • Radial artery Homologous vein • Cryopreserved • Transplanted Biological prostheses • Cadaveric xenografts • Human umbilical vein Synthetic prostheses • PTFE • Dacron • Polyurethane Issues Operating time Graft performance Co-morbidity Patient QOL Product cost Availability Immunosuppression Durability Traceability Cost, supply Patency Infections Handling Biosynthetic <strong>prosthesis</strong> • Ovine collagen with integral polyester mesh • Combines biological and synthetic properties • Good long-term patency • Resistance to infection and aneurysm formation • Excellent handling properties • Available off the shelf • More than 25 years of clinical experience BN 9-12(0)-1
Page 1 and 2: Omniflow II biosynthetic vascular p
Page 3 and 4: The Biosynthetic Solution • Smoot
Page 5 and 6: Omniflow II Non-porous and biocompa
Page 7 and 8: The Clinical Solution • Periphera
Page 9: Arteriovenous access First choice w

Omniflow II biosynthetic vascular prosthesis - Adef-Rio

Create successful ePaper yourself

Delete template?

Save as template?